Lipella Pharmaceuticals Inc. (LIPO) Total liabilities 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) total liabilities at each fiscal year-end, per SEC filings.
$754,417FY2024 · since FY2021: $589,337 → $754,417
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $754,417 | +74.3% |
| FY2023 | $432,726 | -66.0% |
| FY2022 | $1.3M | +116.3% |
| FY2021 | $589,337 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LIPO financial trends
LIPO RevenueLIPO Net incomeLIPO Net marginLIPO Gross profitLIPO Gross marginLIPO Operating incomeLIPO Operating marginLIPO Operating cash flowLIPO Free cash flowLIPO Capital expendituresLIPO Return on equityLIPO Stock buybacksLIPO Dividends paidLIPO Total assetsLIPO Shareholders’ equityLIPO overview →